AI in drug development is a vague term that might mean many things, and today, Owkin is announcing it has enrolled the first patient in a phase 1 study of OKN4395, its “AI-optimized” candidate for ...

Cohere Health®, a recognized leader in clinical intelligence, announces Cohere Connecttm, offering health plans the tools and support to meet and exceed the prior authorization (PA) compliance ...

Cohere Health®, a recognized leader in clinical intelligence, announces Cohere Connect™, offering health plans the tools and support to meet and exceed the prior authorization (PA) compliance mandates ...

Can Artificial Intelligence (AI) make people healthy and happy? Abhijit Khasnis, the Chief Technology Officer at Healthify, ...

BOSTON & SAN FRANCISCO & FORT WORTH, Texas--(BUSINESS WIRE)--Cohere Capital Partners (“Cohere”), a Boston-based private equity firm focused on investing in leading tech-enabled lower middle ...

Cohere Capital Partners (“Cohere”), a Boston-based private equity firm focused on investing in leading tech-enabled lower middle market companies, announced today that it has closed Cohere ...

Cohere's next-generation transformation solutions now support over 16 million health plan members, process 12 million prior authorization requests annually, and streamline prior authorization for ...

"We are extremely proud of our accomplishments in 2024," said Siva Namasivayam, CEO, Cohere Health. "Our team is growing quickly to meet market demand to streamline a burdensome part of healthcare ...

Cohere, an AI startup focused on enterprise technology, unveiled North on Thursday — an all-in-one platform combining large language models, multimodal search, and agents to help its customers ...